356. Danny Yeung, CEO of IM8

Today, I'm joined by Danny Yeung, CEO of IM8. Pivoting from diagnostics, parent company Prenetics has scaled its science-backed supplement brand co-founded with David Beckham to a $400M+ market cap with just two core SKUs. In this episode, we discuss building IM8 from the ashes of a billion-dollar collapse. We also cover: From billion-dollar IPO to $50M valuation in 18 months Simple products, simple messaging General Catalyst's revenue-based financing   Subscribe to the podcast → insider.fitt.co/podcast  Subscribe to our newsletter → insider.fitt.co/subscribe  Follow us on LinkedIn → linkedin.com/company/fittinsider    IM8 Website: https://im8health.com/  IM8 on Instagram: https://www.instagram.com/im8health/    The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart fitness ecosystem for fitness and health facilities.   Fitt Talent: https://talent.fitt.co/  Consulting: https://consulting.fitt.co/  Investments: https://capital.fitt.co/    (00:00) Introduction (01:31) Danny's background (01:50) Prenetics diagnostics journey (02:09) COVID testing boom and collapse (06:03) Meeting David Beckham (02:09) From $1B to $50M (08:58) Prenetics to IM8 pivot (12:28) Organizational strategy (16:22) Product development approach (27:58) Retention and data focus (25:55) Marketing and messaging (29:39) Scaling challenges (30:30) General Catalyst financing model (34:55) Product roadmap (38:11) Where to follow (39:35) Conclusion